{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:21:33Z","timestamp":1787678493628,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110159","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:31:14Z","timestamp":1782714674000},"page":"110159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical drug-oriented design, synthesis, and pharmacological evaluation of novel dual-target antiepileptic hybrid molecules"],"prefix":"10.1016","volume":"180","author":[{"given":"Zhicheng","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110159_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bioorg.2026.110159_bb0010","doi-asserted-by":"crossref","first-page":"Itc49","DOI":"10.7326\/ANNALS-25-00494","article-title":"Epilepsy","volume":"178","author":"Krishnamurthy","year":"2025","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.110159_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.actbio.2025.01.046","article-title":"Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics","volume":"194","author":"Zhang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioorg.2026.110159_bb0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in Epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2026.110159_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-med-050522-034458","article-title":"Advances in therapy for refractory Epilepsy","volume":"76","author":"Jehi","year":"2025","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2026.110159_bb0030","first-page":"723","article-title":"Drug resistance in epilepsy, the lancet","volume":"22","author":"Perucca","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.bioorg.2026.110159_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamaneurol.2022.4699","article-title":"Association between antiepileptic drugs and incident Parkinson disease","volume":"80","author":"Belete","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11064-021-03332-y","article-title":"Alzheimer's disease and Epilepsy: a perspective on the opportunities for overlapping therapeutic innovation","volume":"46","author":"Lehmann","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2026.110159_bb0045","doi-asserted-by":"crossref","unstructured":"S.J. Nevitt, M. Sudell, S. Cividini, A.G. Marson, C. Tudur Smith, Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data, Cochrane Database Syst. Rev., 4 (2022) Cd011412.","DOI":"10.1002\/14651858.CD011412.pub4"},{"key":"10.1016\/j.bioorg.2026.110159_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157015909788848866","article-title":"Antiepileptic drug monotherapy: the initial approach in epilepsy management","volume":"7","author":"St Louis","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","article-title":"New epilepsy therapies in development","volume":"23","author":"Klein","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110159_bb0060","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1038\/s41598-024-61393-9","article-title":"Antiseizure adverse drug reaction and associated factors among epileptic patients at Jimma medical Center: a prospective observational study","volume":"14","author":"Bayane","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110159_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","article-title":"Antiepileptic drugs and liver disease","volume":"77","author":"Vidaurre","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0070","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with Epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.bioorg.2026.110159_bb0075","article-title":"Stiripentol add-on therapy for drug-resistant focal epilepsy","volume":"9","author":"Brigo","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2026.110159_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of Epilepsy","volume":"12","author":"L\u00f6scher","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0085","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2174\/1570159X22666240524160126","article-title":"Multi-target phenylpropanoids against epilepsy","volume":"22","author":"Rodrigues","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fnins.2016.00492","article-title":"Monoaminergic mechanisms in Epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs","volume":"10","author":"Svob Strac","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110159_bb0095","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/med.22057","article-title":"Rethinking therapeutic strategies of dual-target drugs: an update on pharmacological small-molecule compounds in cancer","volume":"44","author":"Yang","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110159_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117453","article-title":"Research progress and perspectives of dual-target inhibitors","volume":"289","author":"Pang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110159_bb0105","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1039\/D2SC03298H","article-title":"Dual targeting nanoparticles for epilepsy therapy","volume":"13","author":"Hou","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110159_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101311","article-title":"Microbiota in drug resistance","volume":"84","author":"Jia","year":"2026","journal-title":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.bioorg.2026.110159_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118587","article-title":"Multi-target incretin-based therapeutics: the rise of dual and triple agonists for metabolic disorders","volume":"305","author":"Alavi","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110159_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/s13679-025-00681-5","article-title":"Pharmacological management of diabesity: current and emerging therapies","volume":"15","author":"Galasso","year":"2026","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.bioorg.2026.110159_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102386","article-title":"Cannabidiol and neurodegeneration: from molecular mechanisms to clinical benefits","volume":"100","author":"Jha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110159_bb0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110159_bb0135","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","article-title":"Memantine: a review of its use in Alzheimer's disease","volume":"66","author":"Robinson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110159_bb0140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40263-015-0287-2","article-title":"Memantine ER\/donepezil: a review in Alzheimer's disease","volume":"29","author":"Greig","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2026.110159_bb0145","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1038\/s41467-025-65781-1","article-title":"Structural pharmacology of SV2A reveals an allosteric modulation mechanism in the major facilitator superfamily","volume":"16","author":"Pidathala","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110159_bb0150","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Na(v)1.7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110159_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/acs.jafc.5c10117","article-title":"Natural product-inspired fungicide discovery: tryptamine derivatives as novel CYP51 inhibitors for combating fungal infections and ensuring food safety","volume":"74","author":"Zhang","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.110159_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2025.146505","article-title":"Identification of new coumarin-cinnamic acid hybrid FtsZ inhibitors as potential bactericides for enhancing the yield and quality of rice","volume":"495","author":"Zhang","year":"2025","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2026.110159_bb0165","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1002\/ps.8895","article-title":"Novel 2,5-dihydro-3H-[1,2,4]triazino[5,6-b]indole derivatives decorated with disulfide moiety are effective for treating bacterial infections by inducing reactive oxygen species","volume":"81","author":"Wang","year":"2025","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.bioorg.2026.110159_bb0170","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110159_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioorg.2026.110159_bb0180","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110159_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:48:19Z","timestamp":1787676499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S0045206826006954"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110159","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical drug-oriented design, synthesis, and pharmacological evaluation of novel dual-target antiepileptic hybrid molecules","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110159"}}